European Prostate Cancer Device Market Will Be Driven By Earlier Detection Of Prostate Cancer, According To Millennium Research Group

Main Category: Prostate / Prostate Cancer
Also Included In: Medical Devices / Diagnostics;  Urology / Nephrology
Article Date: 08 Dec 2008 - 3:00 PDT

email to a friend   printer friendly   opinions  

According to Millennium Research Group's (MRG's) European Markets for Urological Devices 2009 report, the prostate cancer device market-comprising brachytherapy seeds, cryotherapy, and high-intensity focused ultrasound (HIFU) devices-will be driven by earlier detection of prostate cancer due to an increase in screening over the next five years.

Screening allows for early detection of cancer, enabling treatment at a curable stage that can be facilitated through minimally invasive devices, such as those required for brachytherapy, cryotherapy, and HIFU procedures.

Brachytherapy seeds will remain the largest prostate cancer device segment due to greater physician confidence in brachytherapy procedures and better access to reimbursement and equipment. Both cryoablation and HIFU will remain comparatively small segments; however, both will gain popularity over the next five years as access to equipment and training improves and more urologists gain experience with these procedures.

"To aid in our research we conducted a survey of almost 40 European physicians," says Lexie Code, Manager of the Endoscopy division at MRG. "When asked whether they perform each technique, the most popular-used by 66.7% of participants-was brachytherapy. 52.4% have used HIFU, and 9.5% Cryoablation. Some used more than one of these techniques as well."

MRG's European Markets for Urological Devices 2009 report provides coverage of key industry competitors, including Coloplast, Astra Tech, KARL STORZ, C. R. Bard.

About Millennium Research Group

Millennium Research Group, a Decision Resources, Inc. company, is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions. www.MRG.net

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

• Additional
• References
• Citations